|
|
Dendreon Corporation
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Dendreon Annual Meeting notes - WOW!Now that was a thorough job, thank you very much! You painted a very clear picture and I felt like I was there with everyone.
"Provenge's initial label will cover approximately 100,000 patients annually. He showed the 9901 and 9902B data. (I was surprised to see curves on the 9902B data eventually collapse, and I am sure someone on the board can explain that.) "
The curves eventually collapse because Provenge does not provide immortal life! Eventually, everyone (both placebo and those on Provenge) will die, either due to PC, or due to other causes.
Thanks again! |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 283015 | Re: Dendreon Annual Meeting notes - WOW! | bobrmd | 11 | 6/10/2009 7:51:28 PM |
